---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-001270"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2021-08-11T23:59:59+00:00"
generated_at: "2026-06-29T15:39:35.243025+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LifeStance Health Q2 revenue $160.5M (+91% YoY), initiates FY2021 guidance

## Summary
- Revenue $160.5M, up 91% YoY; net loss $70M includes $29.5M stock comp and $10M foundation endowment.
- Adjusted EBITDA $14.5M (+39% YoY); total clinicians 3,975, up 94% YoY.
- IPO completed June 10, net proceeds $548.9M used to retire debt and for corporate purposes.
- FY2021 guidance: revenue $668M-$678M, Center Margin $198M-$208M, Adjusted EBITDA $47M-$53M.
- Opened 35 de novo centers, entered 5 new states, completed 10 acquisitions in Q2.

## SEC filing metadata
- accession: 0000950170-21-001270
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2021-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017021001270/0000950170-21-001270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017021001270/lfst-20210811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-001270
- JSON: https://secwatch.observer/filing/0000950170-21-001270.json
- Plain text: https://secwatch.observer/filing/0000950170-21-001270.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.